Trials / Completed
CompletedNCT01288924
Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?
Can Preemptive Analgesia With Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain? A Double-blinded, Randomized, Placebo-controlled Trial.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Chiang Mai University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.
Detailed description
The incidence of Post-operative Ipsilateral Shoulder Pain (PISP) varies from 21-97% after thoracic surgery, despite receiving effective thoracic epidural analgesia. This pain has been described as constant, aching in quality, unrelated to position change or respiration. Possible causes of shoulder pain includes injury of the phrenic nerve, the lateral decubitus position, transection of major bronchus or preexisting arthritis condition. The possibilities of prevention and management of PISP are taken into consideration. Thoracic epidural block will be performed in all patients before general anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Parecoxib | Parecoxib 40 mg intravenous before surgery and every 12 hours for two days. |
| OTHER | Control | NSS 2 ml intravenous before surgery and every 12 hours for two days. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2015-10-01
- Completion
- 2016-01-01
- First posted
- 2011-02-03
- Last updated
- 2016-12-06
Locations
2 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01288924. Inclusion in this directory is not an endorsement.